West Island Brands - CEO, Boris Ziger
CEO, Boris Ziger
Source: Small Cap Power
  • West Island Brands (WIB) has completed the first tranche a non-brokered private placement for gross proceeds of $270,000.00
  • The company issued 1,080,000 units at a price of $0.25 per unit
  • The proceeds of private placement will be used for general working capital purposes
  • West Island Brands, formerly Matica Enterprises, is a company focused on the medical marijuana industry
  • Shares in West Island Brands Inc. (WIB) are unchanged, trading at C$0.59 per share at 1:15 pm EST

West Island Brands (WIB) has completed the first tranche a non-brokered private placement for gross proceeds of $270,000.00.

The company issued 1,080,000 units at a price of $0.25 per unit. Each unit is comprised of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share at a price of $0.25 for a period of 24 months from the closing date of the offering.

The proceeds of the private placement will be used for general working capital purposes.

All securities purchased under this financing are subject to a four-month hold period.

Finder’s fees consisting of cash and broker warrants were paid in accordance with the policies of the CSE. Completion of the financing is subject to the acceptance of the CSE.

West Island Brands, formerly Matica Enterprises, is a company focused on the medical marijuana industry. Its projects include Dorval, Ionic mist, Hemmingford, and others.

West Island Brands Inc. (WIB) is unchanged on the day, trading at C$0.59 per share at 1:15 pm EST.

More From The Market Online
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Quarterly report season heats up

Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.